Skip Main Navigation
Page Content
This event has ended

PSM Congressional Briefing

Partnership for Safe Medicines (PSM)

Thursday, March 15, 2012 from 12:00 PM to 1:30 PM (EDT)

PSM Congressional Briefing

Ticket Information

Type End Quantity
General Public Ended Free  
Government Employee Ended Free  

Share PSM Congressional Briefing

Event Details

Moving Beyond the Avastin Incident:
The Continued Impact of Counterfeit Drugs in the United States

 

Last month, the U.S. Food and Drug Administration (FDA) issued a warning to healthcare professionals and patients that a counterfeit version of the cancer drug Avastin may have been purchased and used by some medical practices in the United States. Analysis showed that the fake cancer drug did not contain any of Avastin's active ingredient and instead contained substances ranging from starch and salt to solvent chemicals like acetone, which is used in paint thinner.

Please join the Partnership for Safe Medicines as we explore the continued impact of counterfeit drugs on Thursday, March 15 in the Congressional Visitor Center, Room HVC-201. This free luncheon briefing will start at noon and conclude at 1:30 p.m. 

For more information, please contact Tara Goodin at 202-591-4041 or tara@safemedicines.org.

Have questions about PSM Congressional Briefing? Contact Partnership for Safe Medicines (PSM)

When & Where


Capitol Hill
E Capitol St NE & 1st St NE
Washington, DC 20001

Thursday, March 15, 2012 from 12:00 PM to 1:30 PM (EDT)


  Add to my calendar

Organizer

Partnership for Safe Medicines (PSM)

Comprised of more than 65 non-profit organizations, PSM is a public health group committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard or otherwise unsafe medicines. 

  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.